Correlation Between Algernon Pharmaceuticals and Mind Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and Mind Medicine, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Mind Medicine.

Diversification Opportunities for Algernon Pharmaceuticals and Mind Medicine

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Algernon and Mind is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Mind Medicine go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and Mind Medicine

Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 14.64 times less return on investment than Mind Medicine. In addition to that, Algernon Pharmaceuticals is 1.62 times more volatile than Mind Medicine. It trades about 0.01 of its total potential returns per unit of risk. Mind Medicine is currently generating about 0.22 per unit of volatility. If you would invest  630.00  in Mind Medicine on September 1, 2024 and sell it today you would earn a total of  187.00  from holding Mind Medicine or generate 29.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Algernon Pharmaceuticals  vs.  Mind Medicine

 Performance 
       Timeline  
Algernon Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Algernon Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Mind Medicine 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mind Medicine are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Mind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point.

Algernon Pharmaceuticals and Mind Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Algernon Pharmaceuticals and Mind Medicine

The main advantage of trading using opposite Algernon Pharmaceuticals and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.
The idea behind Algernon Pharmaceuticals and Mind Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine